Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey

European Respiratory Journal

Volumn 10, Issue 8, 1997, Pages 1795-1802

  Janson, C ^a   Chinn, S ^a   Jarvis, D ^a   Burney, P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Alternative medicine; Asthma; Beta2 agonists; Corticosteroids; Drug utilization; Prevalence

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; NEDOCROMIL;

ARTICLE; ASTHMA; BRONCHODILATATION; CORTICOSTEROID THERAPY; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HERBAL MEDICINE; HUMAN; PREVALENCE; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; AUSTRALIA; BRONCHODILATOR AGENTS; COMMUNITY MEDICINE; COMPLEMENTARY THERAPIES; DEMOGRAPHY; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PHYSICIANS; PREVALENCE; RESPIRATION;

EID: 0030798745     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10081795     Document Type: Article

References (18)

1. Nordic Council on Medicines. Nordic statistics on Medicines 1990-1992. NLN publication No. 34, Uppsala 1993.
2. Sly RM. Changing asthma mortality and sales of inhaled bronchodilators and antiasthmatic drugs. Ann Allergy 1994; 73: 439-443.
3. Van Ganse E, Van der Linden PD, Leufkens HGM, Herings RMC, Vincken W, Ernst P. Asthma medication and disease exacerbations; an epidemiological study as a method for asthma surveillance. Eur Respir J 1995; 8: 1856-1860.
4. Vermeire PA, Wittesaele WW, Janssen E, De Backer WA. European audit of asthma therapy. Chest 1986: 90: 50s-61s.
5. Ruggieri F, Hindle M. Diagnosis and treatment of asthma across Europe. Eur Respir J 1989; 2 (Suppl. 6): 536s-539s.
6. Vermeire P. Differences in asthma management around the world. Eur Respir Rev 1994; 4: 279-281.
7. National Heart, Lung, and Blood Institute, National Institute of Health. International Consensus Report on the diagnosis and management of asthma. NIH publication number 92-3091, 1992.
8. National Institute of Health, National Heart, Lung, and Blood Institute. Global Initiative for asthma. NIH publication number 95-3659, 1995.
9. Burney PGJ, Luczynska C, Chinn S, Jarvis D. The European community respiratory health survey. Eur Respir J 1994; 7: 954-960.
10. European Community Respiratory Health Survey. The prevalence of respiratory symptoms in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9: 687-695.
11. European Community Respiratory Health Survey. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997; 99: 687-695.
12. Francis B, Green M, Payne C, eds. The GLIM system release 4 manual. Oxford, Clarendon Press, 1993.
13. Pearce N, Weiland S, Keil U, et al. Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J 1993; 6: 1455-1461.
14. Burr ML, Limb ES, Andrae S, Barry DMJ, Nagel F. Childhood asthma in four countries: a comparative study. Int J Epidemiol 1994: 23: 341-347.
15. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246-252.
16. MacLennan AH, Wilson DH, Taylor A. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569-573.
17. 2-agonist inhalers and undertreatment of asthma. Br Med J 1993; 306: 1514-1518.
18. De Marco R, Verlato G, Zanolin E, Bugiani M, Drane JW. Nonresponse bias in EC Respiratory Health Survey in Italy. Eur Respir J 1994; 7: 2139-2145.